Business Daily Folgen

Can corporations be repurposed to prioritise society and the environment over profit? Ed Butler discusses the question with BBC Business Editor Simon Jack, who says he sees signs of real change. With a climate emergency upon us, many people in business and finance appear to be having a genuine change of heart about economist Milton Friedman's famous maxim that the corporation's sole purpose should be to maximise shareholder value. Perhaps corporations have other responsibilities too?Among the capitalists talking this new talk are Stephen Badger, chairman of the giant family-owned US confectionary company Mars, and Alan Jope, chief executive of Anglo-Dutch consumer goods conglomerate Unilever.(Picture: A cute piggy bank sits astride a large pile of coins; Credit: Petmal/Getty Images)

When will artificial intelligence be capable of providing intelligent conversation? Jane Wakefield looks at two AI systems that still fall well short in the so-called Turing Test of passing themselves off as human. Amazon's virtual assistant Alexa may be capable of ordering your groceries or even cracking a joke, but shockingly she has never heard of Business Daily. Despite this clear evidence of limited intelligence, head scientist Rohit Prasad insists that his baby has smarts.Meanwhile a more glamorous build-you-own-buddy is Sophia (pictured), the android capable of 60 facial expressions, which apparently was enough to earn her Saudi citizenship. But is she more than just a pretty latex face? Jane speaks to her creator and biggest fan, David Hanson.(Picture: The humanoid robot Sophia, which was granted citizenship in Saudi Arabia; Credit: Pavlo Conchar/SOPA Images/LightRocket via Getty Images)

Facebook and Elon Musk are among those interested in the potential use of brain probes to read minds and enhance human capabilities.Jane Wakefield looks at the technology of inserting electronic implants into the brain, and the ethical implications. Dr Ali Rezai of the Rockefeller Neuroscience Institute uses the probes to treat people with conditions such as epilepsy and drug addiction, but fears where commercialisation of the technology could lead.Jane also speaks to bioethicist Dr Sarah Chan of the UK’s Royal Society; and with Noel Sharkey, professor of artificial intelligence at the University of Sheffield.(Picture: MRI scan of a patient treated with a deep brain stimulation implant at Grenoble University Hospital in France; Credit: BSIP/UIG Via Getty Images)